SLXP News 132.42 10/16/2014 05:45:28 Salix Pharmaceuticals (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Salix Pharmaceuticals (SLXP) 132.42 $SLXP

AbbVie Board To Shareholders: Vote No On Shire Buy
at Investor's Business Daily - Thu Oct 16, 12:22AM CDT
AbbVie (ABBV) late Wednesday said that its board of directors recommendation that shareholders reject a planned $55 billion buy of Shire Pharmaceuticals. The board citing new Treasury rules issued Sept. 22 making tax inversion deals less attractive....
AGN: 177.59 (-4.40), ACT: 217.24 (-4.83), MDT: 62.25 (-1.26), COV: 85.86 (-6.50), SHPG: 170.49 (-74.08), SLXP: 132.42 (-1.16), ABBV: 54.63 (+0.50)


AbbVie sours on $55B Shire deal after tax changes
By The Associated Press - AP - Thu Oct 16, 12:18AM CDT
AbbVie's board is recommending stockholders vote against its $55 billion takeover offer for drugmaker Shire after tax changes reduced the financial advantages of the deal.
MDT: 62.25 (-1.26), SHPG: 170.49 (-74.08), SLXP: 132.42 (-1.16)

Shire Falls, AbbVie Questioned On Buyout Backtrack
at Investor's Business Daily - Wed Oct 15, 12:11PM CDT
Shares of specialty drugmaker Shire plummeted 23% on the stock market today after word got out late Tuesday that big pharma AbbVie is reconsidering its $55 billion buyout of the company. Shire (SHPG) confirmed the reports Wednesday morning with a...
ABT: 40.01 (-1.05), AZN: 68.41 (-1.40), PFE: 28.19 (-0.27), SHPG: 170.49 (-74.08), SLXP: 132.42 (-1.16), MYL: 47.38 (+0.56), ABBV: 54.63 (+0.50)

Stocks Dive, Then Pare Losses; Shire, Expedia, KeyCorp Crumble
at Investor's Business Daily - Wed Oct 15, 9:37AM CDT
Stocks shaved early losses but remained down hard Wednesday as weak economic data hammered away at investor confidence. The S&P 500 showed a 1.7% loss, up from a more than 2% dive in early trade. The Dow Jones industrial average recovered to a 1%...
NFLX: 448.59 (-0.53), EBAY: 50.24 (-0.35), AXP: 80.93 (-1.81), SHPG: 170.49 (-74.08), SLXP: 132.42 (-1.16), TRIP: 78.89 (-0.08), EXPE: 74.10 (-0.65), ABBV: 54.63 (+0.50), KEY: 12.14 (-0.75), INTC: 31.27 (-0.87)

After Yesterday's Decline of 1.25%, Salix Pharmaceuticals Offers Investors Better Value
Comtex SmarTrend(R) - Tue Oct 14, 4:03PM CDT
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $129.91 to a high of $137.99. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $135.09 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLXP: 132.42 (-1.16)

IBD 50: Medical, Internet Companies Top Q3 Estimates
at Investor's Business Daily - Mon Oct 13, 6:15PM CDT
Health care and Internet companies are expected to have some of the strongest third-quarter profit gains in the IBD 50. The consensus analyst estimates for medical leaders Gilead Sciences (GILD) and Lannett (LCI) exceed 200% growth. The June-quarter...
AMBA: 38.60 (+2.94), BIIB: 305.69 (+4.11), ACT: 217.24 (-4.83), VIPS: 185.68 (+8.98), YY: 72.40 (+2.93), SWKS: 49.60 (+0.69), FB: 73.21 (-0.38), AKRX: 34.95 (-0.31), KSU: 115.57 (+0.43), SLXP: 132.42 (-1.16), ATHM: 45.12 (+2.63), LCI: 40.30 (-0.36), ABC: 76.02 (-0.61), GILD: 96.16 (-1.02), AVGO: 72.55 (+0.53)

Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire
PR Newswire - Mon Oct 13, 7:30AM CDT
Today, Analysts Review released its research reports regarding Biogen Idec Inc. (NASDAQ: BIIB), Arrowhead Research Corp. (NASDAQ: ARWR), Salix Pharmaceuticals Ltd. (NASDAQ: SLXP), HCA Holdings, Inc. (NYSE: HCA) and Shire plc (NASDAQ: SHPG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7111-100free.
HCA: 64.84 (-2.14), BIIB: 305.69 (+4.11), ARWR: 6.47 (+0.59), SHPG: 170.49 (-74.08), SLXP: 132.42 (-1.16)

Salix Pharmaceuticals Partnering 2009 Industry Shares, Size, Trend, Analysis, and Forecasts to 2014 by Researchmoz
PRWeb - Sat Oct 11, 11:30PM CDT
The Partnering Agreements with Salix Pharmaceuticals 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.
SLXP: 132.42 (-1.16)

Allergan Raises Outlook amidst Valeant Takeover Attempts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 10, 4:20PM CDT
Allergan Inc. (AGN) raised its third quarter 2014 and full year 2014 earnings guidance.
AGN: 177.59 (-4.40), ACT: 217.24 (-4.83), VRX: 114.34 (-0.60), SLXP: 132.42 (-1.16)

Salix's Rectal Foam Uceris Receives Final FDA Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 5:30PM CDT
Salix Pharmaceuticals, Ltd. (SLXP) announced that the FDA has granted final approval for Uceris rectal foam for the induction of remission in patients with active mild to moderately distal ulcerative colitis.
AGN: 177.59 (-4.40), VRX: 114.34 (-0.60), SHPG: 170.49 (-74.08), SLXP: 132.42 (-1.16)

Salix Pharmaceuticals Set to Possibly Rebound After Yesterday's Selloff of 1.08%
Comtex SmarTrend(R) - Thu Oct 09, 4:57PM CDT
Salix Pharmaceuticals (NASDAQ:SLXP) traded in a range yesterday that spanned from a low of $140.13 to a high of $146.57. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $141.81 on volume of 2.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SLXP: 132.42 (-1.16)

Actavis plc and Valeant Pharmaceuticals Inc. Battle for Allergan Inc.: Who Wins?
George Budwell, The Motley Fool - Motley Fool - Thu Oct 09, 2:52PM CDT
Healthcare companies have been completing merger and acquisitions this year at record pace to counter  ongoing patent cliff troubles, as well as political gridlock in the U.S. over corporate tax reform.  Activist investor Bill Ackman and his hedge...
DRTX: 23.63 (-0.11), AGN: 177.59 (-4.40), VRX: 114.34 (-0.60), ACT: 217.24 (-4.83), SLXP: 132.42 (-1.16)

Allergan Steeply Raises Guidance, Taunts Valeant
at Investor's Business Daily - Thu Oct 09, 10:56AM CDT
Specialty drugmaker Allergan raised its guidance Thursday and took the opportunity to say yet again that Valeant Pharmaceuticals' hostile bid for the company was too low. Allergan (AGN) stock nonetheless was flat in morning trading on the stock...
AGN: 177.59 (-4.40), ACT: 217.24 (-4.83), VRX: 114.34 (-0.60), SLXP: 132.42 (-1.16)

Salix Pharmaceuticals wins US FDA's approval for UCERIS 2mg rectal foam for mild-to-moderate distal ulcerative colitis
M2 - Thu Oct 09, 9:09AM CDT
Medical company Salix Pharmaceuticals (NasdaqGS:SLXP) reported on Wednesday the receipt of the US Food and Drug Administration's (FDA) final approval for UCERIS (budesonide) 2mg rectal foam for the induction of remission in patients with active mild-to-moderate distal ulcerative colitis (UC) extending up to 40cm from the anal verge.
SLXP: 132.42 (-1.16)

FDA Approves UCERIS(R) (Budesonide) 2mg Rectal Foam for the Induction of Remission of Mild-to-Moderate Distal Ulcerative Colitis
Business Wire - Wed Oct 08, 7:30AM CDT
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Food and Drug Administration (FDA) has granted final approval for UCERIS(R) (budesonide) rectal foam for the induction of remission in patients with active mild-to-moderate distal ulcerative colitis (UC) extending up to 40cm from the anal verge. The foam is a rectally administered corticosteroid that overcomes treatment limitations associated with currently approved therapies which are often ineffective due to insufficient distribution of active drug to the distal colon.
SLXP: 132.42 (-1.16)

Salix Pharmaceuticals Partnering 2009 - 2014, New Report Launched
M2 - Wed Oct 08, 7:05AM CDT
Market Research Reports, Inc. has announced the addition of "Salix Pharmaceuticals Partnering 2009-2014" research report to their website http://www.MarketResearchReports.com
SLXP: 132.42 (-1.16)

Salix, Actavis Among Big Cap Pharmas In Merger Mambo
at Investor's Business Daily - Tue Oct 07, 6:33PM CDT
A one-on-one tango has since turned into a full-on hoedown as several major pharmaceutical companies continue to change partners on the M&A floor, with Valeant Pharmaceuticals (VRX) and Pershing Square Capital Management reportedly upping their bid...
DRTX: 23.63 (-0.11), AGN: 177.59 (-4.40), ACT: 217.24 (-4.83), VRX: 114.34 (-0.60), GILD: 96.16 (-1.02), JAZZ: 146.31 (+2.58), SLXP: 132.42 (-1.16), ABBV: 54.63 (+0.50), BMY: 48.96 (+0.04)

Salix Pharmaceuticals
at Investor's Business Daily - Tue Oct 07, 5:59PM CDT
Salix Pharmaceuticals (SLXP), seen as a possible target for Actavis or Allergan, closed down 2.4%, but rose 1% late on the Valeant report.
SLXP: 132.42 (-1.16)

Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene
at Investor's Business Daily - Tue Oct 07, 5:33PM CDT
Actavis has made acquisitions to transform from generic-focused drugmaker into a bigger player in prescription drugs and now finds itself in an enviable position -- thriving, with its home base in Ireland. Expected to generate $15 billion in revenue...
DRTX: 23.63 (-0.11), AGN: 177.59 (-4.40), PRGO: 145.85 (-1.33), VRX: 114.34 (-0.60), ACT: 217.24 (-4.83), PFE: 28.19 (-0.27), SLXP: 132.42 (-1.16), MYL: 47.38 (+0.56), TEVA: 50.09 (+0.19)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 110

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
LNG’s Coming Glut Could Gut Global Trading Profits

Updated Category News Views 33

A five-year LNG surplus is the sort of forecast that makes people nod politely today and panic much too late. Bain & Company is putting a hard edge on that risk: the global trading profit pool could slide from an estimated $20 billion in 2026 to roughly $5.5 billion a year during a 2030–34 glut, then potentially tip below zero once cancellation costs bite. That is not a...

Continue Reading
24X Options Filing Puts Earnings Bets Before the SEC

Updated Category News Views 126

An earnings release already turns the market into a bar fight; 24X wants to put part of that fight inside a regulated binary-options contract. The Stamford-based exchange has filed a proposed rule change with the SEC for 24X Options, a facility that would offer a conventional options market alongside contracts tied to company performance targets. It is an interesting...

Continue Reading
Discount Tire’s $10 Correction Matters This Black Friday

Updated Category News Views 72

A ten-dollar correction is not a catastrophe, but it is precisely the sort of loose screw that deserves a glance before Black Friday shouting gets underway. Discount Tire says an earlier version of its Nov. 17, 2026 promotion release listed combined instant savings of $390 when the correct maximum is $380. The company issued the correction and supplied a revised release....

Continue Reading
Vizsla's Panuco Delay Puts Security Ahead of Speed

Updated Category News Views 34

A mine schedule can absorb a calendar slip; the people around a mine cannot be treated like a line item. Vizsla Silver's update on Panuco is therefore not the usual development-company chest thumping. It is a sober admission that security, permitting and site readiness have pushed first silver to the second half of 2028, one year later than the prior H2 2027 target....

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 0

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading
Shenzhen’s APEC Moment Puts Pacific Trade Links in Focus

Updated Category News Views 80

A city that once logged eight stock trades in a day is hosting APEC with a very different kind of ledger in view. Shenzhen Stock Exchange began trial operations on December 1, 1990 with one stock, eight trades and roughly 200,000 yuan in turnover. By the end of September 2026, it had 2,908 listed companies and about 42.43 trillion yuan in combined market value. That is...

Continue Reading
American Pride Bank Tests a Fast Southeast Expansion

Updated Category News Views 154

Those old Winston-Salem smokestacks make a fitting backdrop for a bank trying to build something new, and American Pride Bank is moving with uncommon speed. Its new office at 450 N. Patterson Ave., Suite 200 sits in the Bailey South building in Innovation Quarter, across from Bailey Park and amid a district deliberately remade for founders, researchers and growing...

Continue Reading
Markley’s Lowell Campus Turns Data Land Into Arboretum

Updated Category News Views 203

Server halls rarely get credited with restoring a landscape, which is why Markley’s Lowell campus caught my eye. On November 18, 2026, the company said its Lowell data center campus had earned Level I arboretum accreditation from the ArbNet Arboretum Accreditation Program. ArbNet describes itself as the only international accreditation program specifically for arboreta,...

Continue Reading
2027 Auto Brand Awards Put Long-Term Buyer Value First Again

Updated Category News Views 32

Car shoppers staring down high prices and financing costs do not need another shiny badge; they need some help separating durable value from showroom wallpaper. That is why the 2027 U.S. News vehicle brand awards, announced Nov. 19, 2026, are worth a look. They are not a sales forecast, not a profit forecast, and certainly not a reason to blindly crown a corporate winner....

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Trailblazers: Equity Prime Mortgage’s TAG 2025 Awards

Updated Category News Views 146

Recognizing Industry Innovators at TAG 2025 Awards spotlight collaboration, innovation, and empowerment shaping the next era of mortgage leadership. Equity Prime Mortgage (EPM), a prominent independent mortgage lender, has unveiled the winners of The American Gift (TAG) 2025 awards, honoring rising stars and leaders in the mortgage industry. During the event, founder and...

Continue Reading
GDS Holdings Set to Announce Q1 2025 Financial Performance

Updated Category News Views 144

GDS Holdings to Announce its First Quarter 2025 Financial Results GDS Holdings Limited, a prominent player in high-performance data center development and operations, is gearing up to share its financial performance for the first quarter of 2025. The announcement is expected to take place shortly before the opening of the U.S. market on May 20, 2025. As an investor and...

Continue Reading
Vineyard Workforce Insights: Skills and Opportunities Ahead

Updated Category News Views 152

Understanding the Vineyard Workforce A groundbreaking survey into the vineyard workforce has been conducted, collecting responses from nearly 1,700 workers. This survey stands as the most extensive study of its kind, yielding fascinating insights into job satisfaction, career aspirations, and the financial landscape of vineyard employees. Insight into Job Satisfaction...

Continue Reading
Explore the New Trading Opportunities with IDEX Biometrics

Updated Category News Views 126

Exciting Developments for IDEX Biometrics ASA Investors Recent efforts by IDEX Biometrics ASA have resulted in noteworthy advancements for its investors. With a strategic focus on growth and innovation, the company has successfully completed a private placement followed by a subsequent offering, significantly enhancing its financial posture. Overview of the Private...

Continue Reading
Celebrate Organic Month with Natural Grocers' Exciting Offers

Updated Category News Views 56

Celebrate Organic Month at Natural Grocers This September This September, Natural Grocers invites everyone to join in the festivities of Organic Month, featuring fantastic discounts, educational programs, and opportunities for fundraising. From September 12 to 14, customers can enjoy three days filled with amazing savings, samples, and freebies, making it the ideal time...

Continue Reading